ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1813

Frequency of Tissue-Specific Activated CD8+ T Cells is Correlated To Disease Severity in Juvenile Idiopathic Arthritis

Abigail Thielbar1, Tracy Ting2, Lexi Auld3, Kelly Rogers4, Megan Quinlan-Waters5, Sheila Angeles-Han4, Ekemini Ogbu2, Daniel Lovell2, Jennifer Huggins6, Grant Schulert2, Yuriy Baglaenko4 and Patricia Vega-Fernandez2, 1Cincinnati Children's Hospital, Cincinnati, 2Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 3Cincinnati Children's Hospital Medical Center, Division of Rheumatology, Cincinnati, OH, 4Cincinnati Children's Hospital, Cincinnati, OH, 5Cincinnati Children's Hospital Medical Center, CCHMC, 6Cincinnati Children's Medical Center, Cincinnati, OH

Meeting: ACR Convergence 2025

Keywords: immunology, Juvenile idiopathic arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, October 28, 2025

Title: (1809–1829) Pediatric Rheumatology – Basic Science Poster

Session Type: Poster Session C

Session Time: 10:30AM-12:30PM

Background/Purpose: Juvenile Idiopathic Arthritis (JIA) is characterized by joint pain and inflammation. Persistent oligoarticular JIA(oligoJIA) is defined by the involvement of up to 4 joints throughout disease course. OligoJIA can progress to an extended form of arthritis (extended-oligoJIA), involving 5 or more joints after the first 6 months of disease. Polyarticular JIA is defined as affecting 5 or more joints in the first 6 months of disease. Over 30% of children with extended-oligoJIA experience uncontrolled disease requiring the use of several immunosuppressive medications even after 8-year follow-up. Moreover, even with current treatment options, 50-60% of children with extended-oligoJIA continue to experience pain, functional disability, disease activity, and impaired quality of life extending into adulthood. There is limited understanding of the cellular composition of inflammatory tissues in JIA, particularly in the affected synovium, which is a major barrier for the identification of disease biomarkers, diagnosis, and therapeutic targeting. The purpose of this study was to identify cell subsets associated with disease progression and severity in the synovium of children with JIA.

Methods: Fourteen synovial tissue biopsies of children with oligoJIA or polyarticular JIA, were collected by ultrasound guided biopsy. Cryopreserved synovial tissue was thawed and enzymatically digested in Liberase and DNAse I, prior to staining with a comprehensive antibody panel encompassing all major immune and non-immune cell types. Matching PBMC samples were also stained for flow analysis from 5 of the individuals. Synovial fluid biomarkers were measured by Luminex.

Results: Flow cytometry analysis revealed significant differences in the cellular composition of B cells, fibroblasts, and T-cell subtypes between PBMC and synovium samples from patients with JIA. Interestingly, we note a significant difference in tissue-specific HLA-DR+ CD8+ activated T cells in polyarticular JIA when compared to oligoJIA. Extending this analysis, we discovered significant correlations of activated and regulatory CD8+ T cell states with Juvenile Arthritis Disease Activity Scores (JADAS). Synovial fluid biomarkers such as IL-18, CD25, IL-6, and IL-23 were similarly correlated to disease activity and the frequency of tissue-specific activated T cells (PD-1+ CD-8+), T peripheral helper cells (HLA-DR+ CD4+), and HLA-DR+ fibroblasts.

Conclusion: With comprehensive flow cytometry analysis, we characterized the heterogenous cellular composition of JIA in both PBMC and disaggregated synovium. We observed increased frequencies of activated T cells specifically within the synovium correlated to disease severity and synovial fluid biomarkers.


Disclosures: A. Thielbar: None; T. Ting: None; L. Auld: None; K. Rogers: None; M. Quinlan-Waters: None; S. Angeles-Han: None; E. Ogbu: Cartesian Therapeutics, 2; D. Lovell: AbbVie, 2, Bristol-Myers Squibb(BMS), 2, Canadian Arthritis Society, 12, DSMB memberNIH-NIAMS and NIAID, Canadian Arthritis Society, Novartis, 2; J. Huggins: None; G. Schulert: IpiNovoyx, 5, Novartis, 2, SOBI, 2; Y. Baglaenko: None; P. Vega-Fernandez: None.

To cite this abstract in AMA style:

Thielbar A, Ting T, Auld L, Rogers K, Quinlan-Waters M, Angeles-Han S, Ogbu E, Lovell D, Huggins J, Schulert G, Baglaenko Y, Vega-Fernandez P. Frequency of Tissue-Specific Activated CD8+ T Cells is Correlated To Disease Severity in Juvenile Idiopathic Arthritis [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/frequency-of-tissue-specific-activated-cd8-t-cells-is-correlated-to-disease-severity-in-juvenile-idiopathic-arthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/frequency-of-tissue-specific-activated-cd8-t-cells-is-correlated-to-disease-severity-in-juvenile-idiopathic-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology